© Reuters. FILE PHOTO: The logo of Bayer AG is pictured during the German drugmaker’s annual results news conference in Leverkusen, Germany February 27, 2019. REUTERS/Wolfgang Rattay
FRANKFURT (Reuters) – German diversified group Bayer (DE:) said on Tuesday it was aiming for a 7% rise in its adjusted core profit at constant currencies this year as demand for its seeds and pesticides being partly offset by investments. in new genetic treatment technologies.
Earnings before interest, tax, depreciation and amortization (EBITDA) before exceptional items is expected to reach €12 billion ($13.4 billion) in 2022, adjusted for currency fluctuations, from €11.18 billion last year. last year, the German company said in a statement on Tuesday. .
($1 = 0.8930 euros)
Merged media or anyone involved with Fusion Media will accept no liability for any loss or damage resulting from reliance on the information, including data, quotes, charts and buy/sell signals contained in this website . Please be fully informed of the risks and costs associated with trading in the financial markets, it is one of the riskiest forms of investment possible.